New Supply Chain Appointments At Mawdsleys

Mawdsleys have recently announced new appointments in the business which will strengthen further the procurement capacity and support the supply chain for hospital customers.

 

Gary Winkle has been appointed as the new Purchasing Director alongside Penry Price who joins the company to head up the Generic Purchasing Division. Penry, who joins Mawdsleys from Alliance Healthcare, and Gary, from Co-op Pharmacy, have been appointed to replace existing Purchasing Director Gerry Kennedy, upon his imminent retirement.

 

Working closely with Mawdsleys’ Supply Chain Manager, Kevin Buttress, both Penry and Gary are keen to support the development of Mawdsleys’ relationship with manufacturers. Together they have many plans to optimise the hospital supply chain, such as:

 

– Liaising closely with manufacturers to ensure stock levels are maximised for hospital usage requirements

– Increasing the stock level for new CMU contracted products from day one of new contracts

– Ensuring access to timely information in the event of supply chain shortages

– Ensuring local depot stock information is available at all times to hospitals

– Moving products between depots as required to maximise stock levels

– Contingency planning as required

 

Mawdsleys’ Supply Chain Manager, Kevin Buttress, says: “It’s great to be working with Gary and Penry to strengthen manufacturer relationships. With the support of the Mawdsleys Hospital Contracts Team, and Customer Services Team we are optimising the supply chain so hospital customers have access to the products they need, and ensuring that where problems with supply arise, these are communicated in a timely manner.”

 

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-and-meabco-launch-a-named-patient-supply-program-for-bp-c1/ thumbnail image Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Read more
https://www.mawdsleys.co.uk/news/meet-the-mpw-team/ thumbnail image Meet the MPW Team

With over 50 years’ combined experience across the Mawdsleys group, our dedicated MPW team have a vast understanding of the healthcare supply chain with background in the pre-wholesale, logistics, regulatory and clinical trials areas of the business. We are able to provide a flexible and highly reliable solution along with…

Read more
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.